Sarepta Therapeutics
Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
SRPT Key Statistics
Stock Snapshot
With a market cap of 1.57B, Sarepta Therapeutics(SRPT) trades at $14.90. The stock has a price-to-earnings ratio of -15.41.
During the trading session on 2026-08-02, Sarepta Therapeutics(SRPT) shares reached a daily high of $15.65 and a low of $14.84. At a current price of $14.90, the stock is +0.4% higher than the low and still -4.7% under the high.
Trading volume for Sarepta Therapeutics(SRPT) stock has reached 3.6M, versus its average volume of 2.97M.
Over the past 52 weeks, Sarepta Therapeutics(SRPT) stock has traded between a high of $25.32 and a low of $14.68.
Over the past 52 weeks, Sarepta Therapeutics(SRPT) stock has traded between a high of $25.32 and a low of $14.68.
SRPT News
Sarepta Therapeutics (SRPT) is back in focus after the board appointed Michael Severino, M.D., as chief executive and director, with his tenure beginning July 2...
Sarepta Therapeutics has appointed Michael Severino, M.D., a veteran of AbbVie, Amgen, Merck and most recently Tessera Therapeutics, as its Chief Executive Offi...
Morgan Stanley notes that Sarepta (SRPT) announced the appointment of Michael Severino as CEO succeeding Doug Ingram, who will remain in an advisory role throug...
Analyst ratings
46%
of 26 ratingsMore SRPT News
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Sarepta (SRPT) Therapeutics announced the appointment of Michael Severino, M.D., as chief executive officer, effective July 28, 2026. Severino, who was previous...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.